Gynecologic Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gynecologic Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Featuring perspectives from Dr Floor J Backes, including the following topics: Available data with and clinical investigator perspectives on trastuzumab deruxtecan for the management of gynecologic cancers (0:00) Patient-specific factors guiding treatment selection and sequencing for ovarian cancer (OC) (6:05) Management of adverse events associated with PARP inhibitor maintenance therapy for OC; safety concerns in the later-line setting (15:00) Management approaches for ocular toxicity and other adverse events associated with mirvetuximab soravtansine (20:28) Current role of upifitamab rilsodotin in the management of OC and available data with tumor treating fields (24:38) Investigator perspectives on the current chemotherapy shortage; recently published Phase III data with chemoimmunotherapy for endometrial cancer (29:11) Tisotumab vedotin for cervical cancer (36:34) CME information and select publications